| P50 | author | Bahman Yousefi | Q47985240 |
| | Maryam Majidinia | Q57131839 |
| | Alireza Sadeghpour | Q83016047 |
| P2093 | author name string | Bahman Yousefi | |
| | Maryam Majidinia | |
| | Alireza Sadeghpour | |
| P2860 | cites work | Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis | Q43299277 |
| | Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2. | Q43832936 |
| | Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. | Q44058493 |
| | Local anabolic effects of growth hormone on intact bone and healing fractures in rats | Q44687468 |
| | Bone regeneration for murine femur fracture by gelatin hydrogels incorporating basic fibroblast growth factor with different release profiles | Q44758271 |
| | Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/β-TCP): an alternative to autogenous bone graft | Q45862621 |
| | Jagged1 immobilization to an osteoconductive polymer activates the Notch signaling pathway and induces osteogenesis | Q46287864 |
| | PKCδ is required for Jagged-1 induction of human mesenchymal stem cell osteogenic differentiation | Q46662140 |
| | Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects | Q46984461 |
| | PDGF receptor beta is a potent regulator of mesenchymal stromal cell function | Q47774852 |
| | Differences in expression of Wnt antagonist Dkk1 in healthy versus pathological bone samples | Q48011864 |
| | Identification of a dual leucine zipper kinase involved in rat fracture repair | Q48830317 |
| | Insulin-like growth factor-1 promotes osteogenic differentiation and collagen I alpha 2 synthesis via induction of mRNA-binding protein LARP6 expression | Q50215879 |
| | Pro-osteogenic topographical cues promote early activation of osteoprogenitor differentiation via enhanced TGFβ, Wnt, and Notch signaling. | Q50748021 |
| | Insulin-like growth factor-1 (IGF-1) enhances the osteogenic activity of bone morphogenetic protein-6 (BMP-6) in vitro and in vivo, and together have a stronger osteogenic effect than when IGF-1 is combined with BMP-2. | Q50980395 |
| | Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor. | Q51752438 |
| | Comparison between polyurethanes containing castor oil (soft segment) and cancellous bone autograft in the treatment of segmental bone defect induced in rabbits. | Q51814948 |
| | Bone regeneration is regulated by wnt signaling. | Q51978189 |
| | LPS-stimulated inflammation inhibits BMP-9-induced osteoblastic differentiation through crosstalk between BMP/MAPK and Smad signaling. | Q55031815 |
| | Insulin-like growth factor 1 can promote proliferation and osteogenic differentiation of human dental pulp stem cells via mTOR pathway. | Q55070268 |
| | The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation | Q24292169 |
| | MADR1, a MAD-related protein that functions in BMP2 signaling pathways | Q24317247 |
| | The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis | Q24321476 |
| | Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK | Q24338390 |
| | Developmental Drift and the Role of Wnt Signaling in Aging | Q26739045 |
| | Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases | Q26750589 |
| | Using mesenchymal stem cells as a therapy for bone regeneration and repairing | Q26777025 |
| | Role of mesenchymal stem cells in bone regeneration and fracture repair: a review | Q26825380 |
| | The role of stem cells in fracture healing and nonunion | Q26859369 |
| | Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications | Q26998695 |
| | Mesenchymal Stem Cells in Bone Regeneration | Q27023598 |
| | Roles of FGF signaling in stem cell self-renewal, senescence and aging | Q27025540 |
| | Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing | Q27307639 |
| | Physiological notch signaling maintains bone homeostasis via RBPjk and Hey upstream of NFATc1 | Q27334560 |
| | High bone density due to a mutation in LDL-receptor-related protein 5 | Q28217891 |
| | Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6 | Q28506732 |
| | Use of allogeneic bone graft in maxillary reconstruction for installation of dental implants | Q40034674 |
| | Repeated administration of exogenous Sodium-hyaluronate improved tendon healing in an in vivo transection model | Q40046653 |
| | Elevated extracellular calcium stimulates secretion of bone morphogenetic protein 2 by a macrophage cell line. | Q40276939 |
| | Regeneration of bone using nanoplex delivery of FGF-2 and BMP-2 genes in diaphyseal long bone radial defects in a diabetic rabbit model | Q40388484 |
| | Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells | Q41331286 |
| | Porous Alpha-Tricalcium Phosphate with Immobilized Basic Fibroblast Growth Factor Enhances Bone Regeneration in a Canine Mandibular Bone Defect Model | Q41775574 |
| | Axin2-expressing cells execute regeneration after skeletal injury | Q42367077 |
| | Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells | Q42820375 |
| | Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor | Q42824205 |
| | Effect of calcium ion concentrations on osteogenic differentiation and hematopoietic stem cell niche-related protein expression in osteoblasts | Q42828729 |
| | Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells | Q42834448 |
| | NVP-BEZ235, a dual pan class I PI3 kinase and mTOR inhibitor, promotes osteogenic differentiation in human mesenchymal stromal cells. | Q43055104 |
| | Regulation of osteoblastogenesis and bone mass by Wnt10b | Q28509048 |
| | Essential role of beta-catenin in postnatal bone acquisition | Q28594492 |
| | Bone regeneration and stem cells | Q28659195 |
| | Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). | Q30868027 |
| | Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures | Q33293287 |
| | The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification | Q33493242 |
| | Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment | Q33575740 |
| | Temporal gene expression profiling during rat femoral marrow ablation-induced intramembranous bone regeneration | Q33721829 |
| | Growth factor regulation of fracture repair. | Q33778850 |
| | Bone regeneration: current concepts and future directions | Q33917394 |
| | Substitutes for autologous bone graft in orthopaedic trauma | Q34179069 |
| | Modulation of the inflammatory response for enhanced bone tissue regeneration | Q34234144 |
| | Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21 | Q34389785 |
| | Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation | Q34423535 |
| | Osteoinduction, osteoconduction and osseointegration | Q34444247 |
| | Regulation of bone mass by Wnt signaling | Q34576629 |
| | Fibroblast growth factors: biology, function, and application for tissue regeneration | Q34591107 |
| | PDGF-AA promotes osteogenic differentiation and migration of mesenchymal stem cell by down-regulating PDGFRα and derepressing BMP-Smad1/5/8 signaling | Q34627291 |
| | FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease | Q34702208 |
| | The biology of fracture healing | Q35017085 |
| | Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. | Q35027636 |
| | Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. | Q35077692 |
| | Control of osteoblast function and regulation of bone mass | Q35128237 |
| | Osteogenesis of Adipose-Derived Stem Cells | Q35755059 |
| | Lifelong accumulation of bone in mice lacking Pten in osteoblasts | Q35844528 |
| | Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. | Q35965439 |
| | Molecular and cellular characteristics of human and non-human primate multipotent stromal cells from the amnion and bone marrow during long term culture | Q35986912 |
| | Molecular regulation of mechanotransduction | Q36032121 |
| | Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development | Q36117930 |
| | Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation | Q36140903 |
| | Current concepts of molecular aspects of bone healing | Q36231316 |
| | FGF2 gene activated matrices promote proliferation of bone marrow stromal cells | Q36259512 |
| | Bone substitutes: an update | Q36269863 |
| | Signal transduction pathways involved in mechanotransduction in bone cells | Q36576065 |
| | Ras-MAPK signaling in osteogenic differentiation: friend or foe? | Q36580618 |
| | Signaling and transcriptional regulation in osteoblast commitment and differentiation | Q36606452 |
| | cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo | Q36663332 |
| | NOTCH signaling in skeletal progenitors is critical for fracture repair | Q36737924 |
| | The clinical use of allografts, demineralized bone matrices, synthetic bone graft substitutes and osteoinductive growth factors: a survey study | Q36823730 |
| | Recombinant human platelet-derived growth factor: biology and clinical applications | Q37091524 |
| | Translating insights from development into regenerative medicine: the function of Wnts in bone biology. | Q37281895 |
| | Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation | Q37339719 |
| | Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice. | Q37351761 |
| | Wnt pathway, an essential role in bone regeneration | Q37363892 |
| | Comparative analysis of gene transcripts for cell signaling receptors in bone marrow-derived hematopoietic stem/progenitor cell and mesenchymal stromal cell populations | Q37372107 |
| | Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones | Q37416452 |
| | Mechanisms of bone repair and regeneration | Q37594308 |
| | BMP2 signaling in bone development and repair | Q37628252 |
| | Notch activation enhances mesenchymal stem cell sheet osteogenic potential by inhibition of cellular senescence | Q37745211 |
| | Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration | Q37834655 |
| | Prospective isolation of human MSC. | Q37852221 |
| | Electrospun scaffolds for bone tissue engineering | Q37852599 |
| | Bone fracture and bone fracture repair | Q37869386 |
| | Effects of inflammatory and anti-inflammatory cytokines on the bone | Q37880163 |
| | Vitamin D metabolism, cartilage and bone fracture repair | Q37887996 |
| | What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells | Q37896986 |
| | Role of FGFs/FGFRs in skeletal development and bone regeneration | Q37989404 |
| | Bone morphogenetic proteins: facts, challenges, and future perspectives. | Q38175809 |
| | PI3K/AKT signaling pathway and cancer: an updated review | Q38217651 |
| | A review of platelet derived growth factor playing pivotal role in bone regeneration | Q38219084 |
| | Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium | Q38338781 |
| | CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture | Q38393198 |
| | BMPs in bone regeneration: Less is more effective, a paradigm-shift | Q38672307 |
| | Response of MAPK pathway to iron oxide nanoparticles in vitro treatment promotes osteogenic differentiation of hBMSCs | Q38794315 |
| | Stem Cells in Bone Regeneration. | Q38850523 |
| | Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment | Q38971951 |
| | Elevated extracellular calcium increases fibroblast growth factor-2 gene and protein expression levels via a cAMP/PKA dependent pathway in cementoblasts | Q39693983 |
| | Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma. | Q39915275 |
| | A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells | Q40016731 |
| P433 | issue | 4 | |
| P304 | page(s) | 2937-2948 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | Journal of Cellular Physiology | Q1524270 |
| P1476 | title | The roles of signaling pathways in bone repair and regeneration | |
| P478 | volume | 233 | |